J. Chad Brown
Net Worth
Last updated:
What is J. Chad Brown net worth?
The estimated net worth of Mr. J. Chad Brown is at least $6,569,573 as of 30 Jul 2021. He has earned $2,891,633 from insider trading and has received compensation worth at least $3,677,940 in NanoString Technologies, Inc..
What is the salary of J. Chad Brown?
Mr. J. Chad Brown salary is $612,990 per year as Senior Vice President of Sales & Marketing in NanoString Technologies, Inc..
How old is J. Chad Brown?
Mr. J. Chad Brown is 67 years old, born in 1958.
What stocks does J. Chad Brown currently own?
As insider, Mr. J. Chad Brown owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| NanoString Technologies, Inc. (NSTG) | Senior Vice President of Sales & Marketing | 9,702 | $0 | $0 |
What does NanoString Technologies, Inc. do?
NanoString Technologies, Inc. develops, manufactures, and sells tools for scientific and clinical research in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; panels with oncology, immunology and infectious disease, and neuroscience applications. Further, the company offers Master Kits, such as ancillary reagents and plasticware to setup and process samples in the nCounter Prep Station and nCounter Digital Analyzer; and Prosigna molecular diagnostic test kits. The company is also developing GeoMx DSP system to enable the field of spatial genomics. It has collaboration with Lam Research Corporation for the research and development of Hyb & Seq technologies; Celgene Corporation for developing LymphMark, an in vitro diagnostic for the treatment of diffuse large B-cell lymphoma; and Parker Institute for Cancer Immunotherapy to develop CAR-T regimens that enhances patient outcomes for various types of cancer. NanoString Technologies, Inc. was incorporated in 2003 and is headquartered in Seattle, Washington.
J. Chad Brown insider trading
NanoString Technologies, Inc.
Mr. J. Chad Brown has made 15 insider trades between 2019-2021, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 34,712 units of NSTG stock on 1 Jun 2020. As of 30 Jul 2021 he still owns at least 9,702 units of NSTG stock.
NanoString Technologies key executives
NanoString Technologies, Inc. executives and other stock owners filed with the SEC:
- Dr. Joseph M. Beechem (67) Chief Scientific Officer and Senior Vice President of R&D
- Mr. David W. Ghesquiere (58) Senior Vice President of Corporation & Bus. Devel.
- Mr. J. Chad Brown (67) Senior Vice President of Sales & Marketing
- Mr. K. Thomas Bailey M.B.A. (56) Chief Financial Officer
- Mr. R. Bradley Gray (48) Chief Executive Officer, Pres & Director